The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis

References

• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• YapTASmithADFerraldeschiRAl-LazikaniBWorkmanPde BonoJSDrug discovery in advanced prostate cancer: translating biology into therapyNat Rev Drug Discov2016151069971827444228
   PubMed Web of Science ®Google Scholar
• ZhaoRWangYZhangMScreening of potential therapy targets for prostate cancer using integrated analysis of two gene expression profilesOncol Lett20171455361536929113170
   PubMed Web of Science ®Google Scholar
• SchitoLSemenzaGLHypoxia-inducible factors: master regulators of cancer progressionTrends Cancer201621275877028741521
   PubMed Web of Science ®Google Scholar
• MakPLiJSamantaSMercurioAMERβ regulation of NF-kB activation in prostate cancer is mediated by HIF-1Oncotarget2015637402474025426450901
   PubMedGoogle Scholar
• XiaoLJChenYYLinPHypoxia increases CX3CR1 expression via HIF-1 and NF-κB in androgen-independent prostate cancer cellsInt J Oncol20124151827183622941344
   PubMed Web of Science ®Google Scholar
• MunafoMRFlintJMeta-analysis of genetic association studiesTrends Genet200420943944415313553
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med200221111539155812111919
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• MantelNHaenszelWStatistical aspects of the analysis of data from retrospective studies of diseaseJ Natl Cancer Inst195922471974813655060
   PubMed Web of Science ®Google Scholar
• BeggCBBerlinJAPublication bias and dissemination of clinical researchJ Natl Cancer Inst19898121071152642556
   PubMed Web of Science ®Google Scholar
• WuFDingSLiXElevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasiaOncotarget2016711120531206226919249
   PubMedGoogle Scholar
• BaoXZFanGMWuZMExpression and significance of HIF-lα in prostate cancerMod Chin Dr201553713
   Google Scholar
• GuoWChenMNHeXLExpression and clinical significance of HIF-l(VEGF and VEGFR-3 in prostate cancerJ Contemp Urol Reproduct Oncol201464231234
   Google Scholar
• RanasingheWKXiaoLKovacSThe role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancersPLoS One201381e5425123342109
   PubMed Web of Science ®Google Scholar
• LiXHeCHXuCBLiYPExpressions and clinical significances of nuclear factor-κB and hypoxia inducible factor-1α in prostate cancerJ Chongqing Med Univ2013388872875
   Google Scholar
• HuangHLuZQDuTThe expression and correlation studies about carbon anhydrase IX (CA-IX) and hypoxia-inducible factor-1 prostate cancerChin J Endourol201265405409
   Google Scholar
• LiWZhangHDLiZQYuZGNiuXDLiZQExpression of VEGF and HIF-1α in prostate adenocarcinoma and their significanceMed J Chin Peoples Liberation Army20122451113
   Google Scholar
• ShiHQZhaiXLLiuQWExpression and clinical significance of HIF-1α in prostate cancerJ Pract Oncol2007389265267
   PubMedGoogle Scholar
• WangLChenZJWangQTExpression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in prostate cancer and its significanceZhonghua Nan Ke Xue2006121575916483162
   PubMedGoogle Scholar
• LekasALazarisACDeliveliotisCThe expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissueAnticancer Res2006264B2989299316886625
   PubMed Web of Science ®Google Scholar
• PingHChenXCWangHChenCHZengFCLuGCExpression and significance of HIF-lα in prostate cancerChin J Urol20042528890
   Google Scholar
• ZhongHSemenzaGLSimonsJWDe MarzoAMUp-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesisCancer Detect Prev2004282889315068831
   PubMedGoogle Scholar
• DuZFujiyamaCChenYMasakiZExpression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissueChin Med J (Engl)2003116121936193914687488
   PubMed Web of Science ®Google Scholar
• ZhongHDe MarzoAMLaughnerEOverexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastasesCancer Res199959225830583510582706
   PubMed Web of Science ®Google Scholar
• TeitelbaumAHBuiCNSpaldingJRTreatment patterns of castration-resistant prostate cancer: a retrospective claims database analysisJ Clin Oncol20123034_suppl198
   Web of Science ®Google Scholar
• RovielloGCoronaSPBonettaACappellettiMRGeneraliDCirculating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancerOnco Targets Ther2017103811381528814879
   PubMed Web of Science ®Google Scholar
• VaupelPMayerAHypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implicationsAdv Exp Med Biol2014812812192424729210
   PubMedGoogle Scholar
• SemenzaGLOxygen sensing, hypoxia-inducible factors and disease pathophysiologyAnnu Rev Pathol201491477123937437
   PubMedGoogle Scholar
• ChristofkHRVander HeidenMGHarrisMHThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumor growthNature2008452718423023318337823
   PubMed Web of Science ®Google Scholar
• DangCVKimJWGaoPYusteinJThe interplay between MYC and HIF in cancerNat Rev Cancer200881515618046334
   PubMed Web of Science ®Google Scholar
• De FrancescoEMLappanoRSantollaMFMarsicoSCarusoAMaggioliniMHIF-1a/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)Breast Cancer Res2013154R6423947803
   PubMed Web of Science ®Google Scholar
• RenJGuoHWuHGPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent mannerOncol Rep20153341929193725647524
   PubMed Web of Science ®Google Scholar
• KarakashevSVReginatoMJProgress toward overcoming hypoxia-induced resistance to solid tumor therapyCancer Manag Res2015725326426316817
   PubMed Web of Science ®Google Scholar
• LuoDWangZWuJJiangCWuJThe role of hypoxia inducible factor-1 in hepatocellular carcinomaBiomed Res Int201420143–440927225101278
   PubMedGoogle Scholar
• ZhangWMengYLiuNWenXFYangTInsights into chemoresistance of prostate cancerInt J Biol Sci201511101160117026327810
   PubMed Web of Science ®Google Scholar
• HarrisALHypoxia – a key regulatory factor in tumour growthNat Rev Cancer200221384711902584
   PubMed Web of Science ®Google Scholar
• KanekoSSatoCShiozawaNSuppressive effect of delta-tocotrienol on hypoxia adaptation of prostate cancer stem-like cellsAnticancer Res20183831391139929491063
   PubMed Web of Science ®Google Scholar
• ShiozawaNSugaharaRNamikiKInhibitory effect of a redox-silent analogue of tocotrienol on hypoxia adaptation in prostate cancer cellsAnticancer Drugs201728328929727926612
   PubMed Web of Science ®Google Scholar